6S9J image
Deposition Date 2019-07-15
Release Date 2020-01-15
Last Version Date 2024-11-06
Entry Detail
PDB ID:
6S9J
Keywords:
Title:
Crystal structure of TfR1 mimicry in complex with GP1 from MACV
Biological Source:
Source Organism:
Machupo virus (Taxon ID: 11628)
Neotoma albigula (Taxon ID: 42408)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.26
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
P 43 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Transferrin receptor 1,Transferrin receptor 1
Gene (Uniprot):TfR1
Chain IDs:B (auth: A), D (auth: C), F (auth: E), H (auth: G)
Chain Length:178
Number of Molecules:4
Biological Source:Neotoma albigula
Polymer Type:polypeptide(L)
Molecule:Pre-glycoprotein polyprotein GP complex
Gene (Uniprot):GPC
Chain IDs:A (auth: B), C (auth: D), E (auth: F), G (auth: H)
Chain Length:168
Number of Molecules:4
Biological Source:Machupo virus
Ligand Molecules
Primary Citation
Rational design of universal immunotherapy for TfR1-tropic arenaviruses.
Nat Commun 11 67 67 (2020)
PMID: 31900422 DOI: 10.1038/s41467-019-13924-6

Abstact

Certain arenaviruses that circulate in rodent populations can cause life-threatening hemorrhagic fevers when they infect humans. Due to their efficient transmission, arenaviruses pose a severe risk for outbreaks and might be exploited as biological weapons. Effective countermeasures against these viruses are highly desired. Ideally, a single remedy would be effective against many or even all the pathogenic viruses in this family. However, despite the fact that all pathogenic arenaviruses from South America utilize transferrin receptor 1 (TfR1) as a cellular receptor, their viral glycoproteins are highly diversified, impeding efforts to isolate cross-neutralizing antibodies. Here we address this problem using a rational design approach to target TfR1-tropic arenaviruses with high potency and breadth. The pan-reactive molecule is highly effective against all arenaviruses that were tested, offering a universal therapeutic approach. Our design scheme avoids the shortcomings of previous immunoadhesins and can be used to combat other zoonotic pathogens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures